 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | KA Imaging |
| Street 1: | 560 Parkside Drive, Unit 3 |
| Street 2: | |
| City: | Waterloo |
| Province: | Ontario |
| Post Code: | N2L 5Z4 |
| Country: | Canada |
| Phone: | +1 226-215-9897 |
| Organization Email: | CHicks@KAImaging.com |
| Web Site: | http://kaimaging.com/ |
| Other Online Presence: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | None |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | 812636991RC0001 |
| Organization Type - Primary: | Private Sector |
| Organization Type - Secondary: | Health |
| Organization Description: | |
| 1)Devote to the development of new and efficient X-ray imaging technologies. We believe that the responsible use of X-ray can make a difference, providing valuable insights and revealing the unknown. We exist with the ambitious goal of positively impacting lives, working hard to achieve innovative X-ray everywhere. 2)We have shown that our Spectral DR detector can help better visualize and diagnose TB through a typical x-ray exam (our detector provides the xray image along with a bone only and soft tissue only image - 3 all together). 3)We believe with early detection using a standard x-ray machines with our special spectral detector can greatly impact the lives of those impacted by this disease. |
|
| Do you know about the UNHLM declaration: | Yes |
Specializations / Areas of Work | |
|
Advocacy Civil Society and Community Engagement Delivery of health services and care Engaging political leaders and ensuring inclusive leadership Funding, including innovative and optimized approach to funding TB Care Provision of drugs, diagnostics and commodities Research and Development Technical Assistance Working on Community, Rights and Gender (CRG) Working on Key Populations related to TB |
Other Organization Information | |
| Total number of staff in your organization: | 51 - 99 |
| Number of full-time staff who are directly involved with TB: | 1 - 5 |
| Number of part-time staff who are directly involved with TB: | 1 - 5 |
| Number of volunteers who are directly involved with TB: | 0 |
| How did you hear about the Stop TB Partnership: | Attendance at a TB related event |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | |
| Why do you wish join the Stop TB Partnership: | Information on developments within the TB world |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | No |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| Based in Canada, some of our founding principles are to help world health issues utilizing our technology. As an example we recently deployed an x-ray system with our Spectral DR to the Kenya Children's Hospital, where they do approx 300 x-rays a month - with many of them resulting in the early screening/diagnosis of TB - allowing them to recommend patients for follow-up much earlier in the development of TB | |
Geographical Reach | |
| Which country is your headquarters located in: | Canada |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Belgium Canada Colombia Democratic People's Republic of Korea Denmark Germany India Indonesia Iran (Islamic Republic of) Italy Jordan Kenya Netherlands New Zealand Nigeria Pakistan Panama Philippines Saudi Arabia Switzerland Thailand Turkey Ukraine United Arab Emirates United States of America |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
New Diagnostics: Donation to Kenya Children's Hospital - Oct 2024 (X-Ray equipment, with Spectral DR and AI for TB detection) Fundamental Research: Working with AI companies to strengthen TB visualization/diagnosis for early screening using Spectral DR technology |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | December 10, 2024 |
| Last updated: | March 31, 2025 |